CM Plus will exhibit at “Regenerative Medicine JAPAN 2026” (held concurrently with BioJapan 2026), taking place from Wednesday, October 7 through Friday, October 9 at PACIFICO Yokohama. We will also be available for individual consultations, so please feel free to visit our booth.
In addition, during the exhibition period, our Director and Technical Advisor Hirohito Katayama will speak at the FIRM Member Presentation (a Regenerative Medicine JAPAN program) on Thursday, October 8, and Yasuyuki Suga of the Engineering Business Division will speak at an exhibitor presentation hosted by Obayashi Corporation on Friday, October 9.
[Notice for Visitors]
This exhibition requires advance registration. Please register to attend beforehand via the official website below.
https://jcd-expo.jp/jp/
Our Booth
Booth No.: R-21
Related Presentations
No participation fee or advance reservation is required to attend. We look forward to seeing you there.
Date/Time: Thursday, October 8, 2026, 12:05–12:15 | Venue: Regenerative Medicine Stage
[Regenerative Medicine JAPAN Program] FIRM Member Presentation, Day 2
CMC, Regulatory Affairs, and GMP Essentials for Regenerative Medicine Innovators — and How to Make Good Use of External Experts
Our Mr. Katayama will speak at the member presentation of the Forum for Innovative Regenerative Medicine (FIRM), a general incorporated association.
Date/Time: Friday, October 9, 2026, 13:50–14:20 | Venue: Presentation Stage C
Obayashi Corporation Exhibitor Presentation
Stream of Bio Business — Challenges and Evolution in Bio-related Facility Engineering
Our Mr. Suga will appear as a panelist, alongside Takeda Pharmaceutical Company and Airex Co., Ltd., at an exhibitor presentation session hosted by Obayashi Corporation.
Related Services for Regenerative Medicine and Cell & Gene Therapy
CM Plus is a hands-on partner that supports every challenge in the regenerative medicine and cell & gene therapy (CGT) field — from leveraging academic knowledge to helping overseas advanced products enter the Japanese market, including business development and partner searches.
For concerns or issues related to PMDA consultations, our regulatory affairs consultants can help, supporting regulatory strategy tailored to each stage of development. Please feel free to contact us.






